Browse by People

Collapse authors list.
Kudo, Masatoshi, Galle, Peter R, Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Llovet, Josep M, Assenat, Eric, Merle, Philippe, Chan, Stephen L et al (show 11 more authors) , Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ikeda, Masafumi, Yamashita, Tatsuya, Vogel, Arndt, Huang, Yi-Hsiang, Abada, Paolo B, Yoshikawa, Reigetsu, Shinozaki, Kenta, Wang, Chunxiao, Widau, Ryan C and Zhu, Andrew X (2021) Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2. JHEP REPORTS, 3 (2). 100215-.

Collapse authors list.
Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke et al (show 17 more authors) , Tsumura, Hidetaka, Kuzuya, Teiji, Isoda, Norio, Moriguchi, Michihisa, Aino, Hajime, Ido, Akio, Kawabe, Naoto, Nakao, Kazuhiko, Wada, Yoshiyuki, Ogasawara, Sadahisa, Yoshimura, Kenichi, Okusaka, Takuji, Furuse, Junji, Kokudo, Norihiro, Okita, Kiwamu, Johnson, Philip James ORCID: 0000-0003-1404-0209 and Arai, Yasuaki (2022) Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma. LIVER CANCER, 11 (4). pp. 354-367.

Collapse authors list.
Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke et al (show 18 more authors) , Tsumura, Hidetaka, Kuzuya, Teiji, Isoda, Norio, Yasui, Kohichiroh, Aino, Hajime, Ido, Akio, Kawabe, Naoto, Nakao, Kazuhiko, Wada, Yoshiyuki, Yokosuka, Osamu, Yoshimura, Kenichi, Okusaka, Takuji, Furuse, Junji, Kokudo, Norihiro, Okita, Kiwamu, Johnson, Philip James ORCID: 0000-0003-1404-0209, Arai, Yasuaki and TACTICS study group, (2020) Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut, 69 (8). pp. 1492-1501.